Skip to main content
. Author manuscript; available in PMC: 2016 Apr 8.
Published in final edited form as: J Med Ethics. 2012 Feb 7;38(6):356–365. doi: 10.1136/medethics-2011-100178

Table 5. Understanding of study design and randomisation*.

Developed country studies Developing country studies


Author Country Understood study design Author Country Understood study design
Van Stuijvenberg et al, 199853 The Netherlands 88% placebo design Moodley et al, 200527 South Africa 49% knew they had a 50% chance of receiving placebo; 19% understood placebo
Criscione et al, 200344 USA 87% placebo design Hill et al, 200823 Ghana 13% understood ‘not all trial capsules were the same’
Howard et al, 198163 USA 86% double blind design Leach et al, 199933 The Gambia 10% placebo design
Harrison et al, 199555 USA 79%
Pope et al, 200346 Canada 76% placebo design
Bergler et al, 198064 USA 64% (at start), 28% (3 months later)

Developed country studies Developing country studies


Author Country Understood randomisation Author Country Understood randomisation

Ravina et al, 201036 USA 90%, yet only 67% understood there was a 1 in 3 chance of receiving placebo Ellis et al, 201018 Mali 80% of adults 90% of parents
Simon et al, 200348 USA 68% of majority English speakers Krosin et al, 200626 Mali 68%
26% of minority English speakers
14% of minority non-English speakers
Bergenmar et al, 200837 Sweden 85% Pace et al, 200528 Thailand 31%
Gammelgaard et al, 200441 Denmark 79% Moodley et al, 200527 South Africa 21%
Criscione et al, 200344 USA 50% Pace et al, 200529 Uganda 19%
Van Stuijvenberg et al, 199853 The Netherlands 50%
Kodish et al, 200442 USA 50%
Howard et al, 198163 USA 43%
Pope et al, 200346 Canada 39%
Benson et al, 198560 USA 33% of depression study, 16% of schizophrenia study
Hietanen et al, 200051 Finland 23%
Schats et al, 200347 The Netherlands 22%
*

Arranged from highest to lowest %.

When broken down into those who had received a written information sheet at least a week before consent, 15% of those who had received the sheet understood that there was a placebo group versus 4% of those who had not received prior written information.